\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ will\\ undergo\\ further\\ testing\\ with\\ urology\\.\ \(0\)\
\-\ normal\\ right\\ kidney\\.\\ \\ normal\\ bladder\\.\\ \\ left\\ kidney\\ with\\ multiple\\ non\\-communicating\\ cysts\\ throughout\\ the\\ cortex\\ is\\ noted\\.\\ \\ hydronephrosis\\ of\\ the\\ left\\ collecting\\ system\\ is\\ seen\\ as\\ well\\.\\ no\\ dilation\\ of\\ the\\ ureters\\ is\\ seen\\.\ \(0\)\
\-\ multicystic\\ dysplastic\\ kidney\\ disease\ \(0\)\
\-\ reflux\\ nephropathy\ \(0\)\
\-\ upj\\ obstruction\ \(0\)\
\-\ multicystic\\ dysplastic\\ kidney\\ disease\ \(0\)\
\-\ early\\ onset\\ autosomal\\ dominant\\ polycystic\\ kidney\\ disease\ \(0\)\
\-\ severe\\ hydronephrosis\\ with\\ cystic\\ dysplasia\\ of\\ the\\ kidney\ \(0\)\
\-\ 8d\\ yo\\ male\\ for\\ follow\\-ip\\ from\\ prenatal\\ ultrasound\\ demonstrating\\ pelviectasis\\ in\\ the\\ left\\ kidney\\.\ \(1\)\
\-\ at\\ this\\ age\\,\\ the\\ differential\\ includes\\ autosomal\\ dominant\\ polycystic\\ kidney\\ disease\\,\\ multicystic\\ dysplastic\\ kidney\\ disease\\,\\ and\\ autosomal\\ recessive\\ polycystic\\ kidney\\ disease\\.\\ \\ \ \(0\)\
\-\ arpkd\\ is\\ a\\ possibility\\,\\ but\\ with\\ a\\ normal\\ right\\ kidney\\,\\ this\\ differential\\ is\\ unlikely\\ as\\ this\\ disease\\ is\\ bilateral\\ and\\ usually\\ fatal\\.\\ \\ early\\ onset\\ adpkd\\ is\\ a\\ possibility\\ and\\ cannot\\ be\\ excluded\\ at\\ this\\ time\\.\\ \\ the\\ leading\\ diagnosis\\ is\\ mcdkd\\ \\â\\€\\“\\ a\\ single\\ dysplastic\\,\\ nonfunctioning\\ kidney\\ filled\\ with\\ non\\-communicating\\ cysts\\.\\ \\ in\\ approximately\\ 15\\-20\\%\\ of\\ this\\ disease\\,\\ hydronephrosis\\ will\\ be\\ present\\ on\\ either\\ the\\ ipsilateral\\ or\\ contralateral\\ side\\.\\ \\ in\\ time\\,\\ the\\ left\\ kidney\\ will\\ become\\ atrophied\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ kidney\\:\\ 0\\.5772952710439636\ \(0\)\
\-\ dysplastic\\:\\ 0\\.28145403007782643\ \(0\)\
\-\ multicystic\\:\\ 0\\.2267148361010241\ \(0\)\
\-\ disease\\:\\ 0\\.21226645476903677\ \(0\)\
\-\ polycystic\\:\\ 0\\.20050417676395751\ \(0\)\
\-\ autosomal\\:\\ 0\\.19559631862841353\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.17598420194014552\ \(0\)\
\-\ is\\:\\ 0\\.13848387435895437\ \(0\)\
\-\ will\\:\\ 0\\.12205091561398577\ \(0\)\
\-\ dominant\\:\\ 0\\.11830794017706678\ \(0\)\
\-\ possibility\\:\\ 0\\.11756501108941106\ \(0\)\
\-\ the\\:\\ 0\\.11351414457769252\ \(0\)\
\-\ this\\:\\ 0\\.108600448668358\ \(0\)\
\-\ 8d\\:\\ 0\\.10108652951726642\ \(0\)\
\-\ mcdkd\\:\\ 0\\.10108652951726642\ \(0\)\
\-\ atrophied\\:\\ 0\\.10108652951726642\ \(0\)\
\-\ cysts\\:\\ 0\\.09579747559503841\ \(0\)\
\-\ early\\:\\ 0\\.09112748121139098\ \(0\)\
\-\ arpkd\\:\\ 0\\.09093312303257961\ \(0\)\
\-\ left\\:\\ 0\\.08624922023379879\ \(0\)\
\-\ pelviectasis\\:\\ 0\\.08572501851836152\ \(0\)\
\-\ nonfunctioning\\:\\ 0\\.08572501851836152\ \(0\)\
\-\ differential\\:\\ 0\\.08214157332261603\ \(0\)\
\-\ onset\\:\\ 0\\.0811778573268137\ \(0\)\
\-\ nephropathy\\:\\ 0\\.07875941358873967\ \(0\)\
\-\ normal\\:\\ 0\\.07742464113411159\ \(0\)\
\-\ upj\\:\\ 0\\.07737248231997779\ \(0\)\
\-\ adpkd\\:\\ 0\\.07673911062958655\ \(0\)\
\-\ time\\:\\ 0\\.07493230619465349\ \(0\)\
\-\ fatal\\:\\ 0\\.07402291164562008\ \(0\)\
\-\ recessive\\:\\ 0\\.07355130907452158\ \(0\)\
\-\ urology\\:\\ 0\\.06937051627607076\ \(0\)\
\-\ ureters\\:\\ 0\\.06875474742952323\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.06541820554898789\ \(0\)\
\-\ contralateral\\:\\ 0\\.06321474159542473\ \(0\)\
\-\ prenatal\\:\\ 0\\.06234177164359836\ \(0\)\
\-\ excluded\\:\\ 0\\.06217513710694125\ \(0\)\
\-\ with\\:\\ 0\\.061886528144566015\ \(0\)\
\-\ seen\\:\\ 0\\.05951749983762645\ \(0\)\
\-\ collecting\\:\\ 0\\.05928061132831734\ \(0\)\
\-\ undergo\\:\\ 0\\.0590287598538356\ \(0\)\
\-\ testing\\:\\ 0\\.0567825160428806\ \(0\)\
\-\ leading\\:\\ 0\\.05618874966148081\ \(0\)\
\-\ become\\:\\ 0\\.05609280977325236\ \(0\)\
\-\ unlikely\\:\\ 0\\.05599769341353453\ \(0\)\
\-\ dilation\\:\\ 0\\.055625188157062626\ \(0\)\
\-\ reflux\\:\\ 0\\.054745282617684715\ \(0\)\
\-\ either\\:\\ 0\\.0522557269947411\ \(0\)\
\-\ demonstrating\\:\\ 0\\.052121410345722284\ \(0\)\
\-\ cortex\\:\\ 0\\.05147321458908093\ \(0\)\
\-\ be\\:\\ 0\\.051283529177369294\ \(0\)\
\-\ filled\\:\\ 0\\.05086084951705543\ \(0\)\
\-\ as\\:\\ 0\\.05078738997232048\ \(0\)\
\-\ of\\:\\ 0\\.04947965843153032\ \(0\)\
\-\ includes\\:\\ 0\\.04915270770383897\ \(0\)\
\-\ bladder\\:\\ 0\\.049051046551615386\ \(0\)\
\-\ single\\:\\ 0\\.04860477196381682\ \(0\)\
\-\ dysplasia\\:\\ 0\\.04841205427379991\ \(0\)\
\-\ system\\:\\ 0\\.04822263106511225\ \(0\)\
\-\ at\\:\\ 0\\.047750424354864755\ \(0\)\
\-\ in\\:\\ 0\\.04717377976766244\ \(0\)\
\-\ throughout\\:\\ 0\\.04648769120287523\ \(0\)\
\-\ obstruction\\:\\ 0\\.04427501666692754\ \(0\)\
\-\ side\\:\\ 0\\.043667248854930694\ \(0\)\
\-\ right\\:\\ 0\\.04191345188518228\ \(0\)\
\-\ further\\:\\ 0\\.04116972471027544\ \(0\)\
\-\ approximately\\:\\ 0\\.040332574714018736\ \(0\)\
\-\ severe\\:\\ 0\\.04001465571507161\ \(0\)\
\-\ usually\\:\\ 0\\.039793028569916275\ \(0\)\
\-\ age\\:\\ 0\\.03968385539254612\ \(0\)\
\-\ yo\\:\\ 0\\.039490013927073714\ \(0\)\
\-\ and\\:\\ 0\\.039184709596361604\ \(0\)\
\-\ ultrasound\\:\\ 0\\.03898909303061874\ \(0\)\
\-\ cystic\\:\\ 0\\.03806922458042543\ \(0\)\
\-\ bilateral\\:\\ 0\\.03397137933946341\ \(0\)\
\-\ noted\\:\\ 0\\.03351384237024388\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03276760906511155\ \(0\)\
\-\ present\\:\\ 0\\.03243509715520073\ \(0\)\
\-\ but\\:\\ 0\\.03125743717584473\ \(0\)\
\-\ multiple\\:\\ 0\\.030917380176621198\ \(0\)\
\-\ well\\:\\ 0\\.03060658713833112\ \(0\)\
\-\ male\\:\\ 0\\.028143517639097407\ \(0\)\
\-\ from\\:\\ 0\\.025104326874724178\ \(0\)\
\-\ or\\:\\ 0\\.021989628816553117\ \(0\)\
\-\ patient\\:\\ 0\\.020559035446094522\ \(0\)\
\-\ no\\:\\ 0\\.020555168411377445\ \(0\)\
\-\ for\\:\\ 0\\.01915846183905133\ \(0\)\
\-\ on\\:\\ 0\\.019090500952184706\ \(0\)\
\-\ can\\:\\ 0\\.0\ \(0\)\
\-\ not\\:\\ 0\\.0\ \(0\)\
